Treatment of Lymphangioleiomyomatosis

To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1991-07, Vol.325 (1), p.63-64
Hauptverfasser: Goodenberger, Daniel M, Dhand, Sandeep, Eliasson, Arn H, Phillips, Yancy Y, Tenholder, Michael F, Goodwin, Thomas Murphy, Zahner, Johannes, Borst, Mathias M, Worth, Heinrich, Raffin, Thomas A, Taylor, James R, Ryu, Jay, Colby, Thomas V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 64
container_issue 1
container_start_page 63
container_title The New England journal of medicine
container_volume 325
creator Goodenberger, Daniel M
Dhand, Sandeep
Eliasson, Arn H
Phillips, Yancy Y
Tenholder, Michael F
Goodwin, Thomas Murphy
Zahner, Johannes
Borst, Mathias M
Worth, Heinrich
Raffin, Thomas A
Taylor, James R
Ryu, Jay
Colby, Thomas V
description To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point. "Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .
doi_str_mv 10.1056/NEJM199107043250115
format Article
fullrecord <record><control><sourceid>mms_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1056_NEJM199107043250115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NJ199107043250115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</originalsourceid><addsrcrecordid>eNp9j0tLw0AUhQdRaqz-AhG6cSXRe-eRmVlKqS-ibrIPk-SOpnSakomL_nsjKa7EszmLw3fgY-wS4RZBZXdvq5dXtBZBgxRcAaI6YgkqIVIpITtmCQA3qdRWnLKzGNcwBqWdsRkHmWlUCbsuenJDoO2w6Pwi34fdp9t-tN2G2i7su-CGLrbxnJ14t4l0ceg5Kx5WxfIpzd8fn5f3eVpzo4fU6owjkgMErpzzRkiDpGqytWykVVRr1J6UbypDWvPKuwakMgKMV40Vcyam27rvYuzJl7u-Da7flwjlj3L5h_JIXU3U7qsK1PwyB8dxv5n2EGK5pXX49-0bRDBc-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of Lymphangioleiomyomatosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</creator><creatorcontrib>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</creatorcontrib><description>To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point. "Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199107043250115</identifier><identifier>PMID: 2046715</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adolescent ; Combined Modality Therapy ; Female ; Humans ; Lymphangiomyoma - therapy ; Male</subject><ispartof>The New England journal of medicine, 1991-07, Vol.325 (1), p.63-64</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199107043250115$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199107043250115$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2046715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goodenberger, Daniel M</creatorcontrib><creatorcontrib>Dhand, Sandeep</creatorcontrib><creatorcontrib>Eliasson, Arn H</creatorcontrib><creatorcontrib>Phillips, Yancy Y</creatorcontrib><creatorcontrib>Tenholder, Michael F</creatorcontrib><creatorcontrib>Goodwin, Thomas Murphy</creatorcontrib><creatorcontrib>Zahner, Johannes</creatorcontrib><creatorcontrib>Borst, Mathias M</creatorcontrib><creatorcontrib>Worth, Heinrich</creatorcontrib><creatorcontrib>Raffin, Thomas A</creatorcontrib><creatorcontrib>Taylor, James R</creatorcontrib><creatorcontrib>Ryu, Jay</creatorcontrib><creatorcontrib>Colby, Thomas V</creatorcontrib><title>Treatment of Lymphangioleiomyomatosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point. "Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</description><subject>Adolescent</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphangiomyoma - therapy</subject><subject>Male</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9j0tLw0AUhQdRaqz-AhG6cSXRe-eRmVlKqS-ibrIPk-SOpnSakomL_nsjKa7EszmLw3fgY-wS4RZBZXdvq5dXtBZBgxRcAaI6YgkqIVIpITtmCQA3qdRWnLKzGNcwBqWdsRkHmWlUCbsuenJDoO2w6Pwi34fdp9t-tN2G2i7su-CGLrbxnJ14t4l0ceg5Kx5WxfIpzd8fn5f3eVpzo4fU6owjkgMErpzzRkiDpGqytWykVVRr1J6UbypDWvPKuwakMgKMV40Vcyam27rvYuzJl7u-Da7flwjlj3L5h_JIXU3U7qsK1PwyB8dxv5n2EGK5pXX49-0bRDBc-w</recordid><startdate>19910704</startdate><enddate>19910704</enddate><creator>Goodenberger, Daniel M</creator><creator>Dhand, Sandeep</creator><creator>Eliasson, Arn H</creator><creator>Phillips, Yancy Y</creator><creator>Tenholder, Michael F</creator><creator>Goodwin, Thomas Murphy</creator><creator>Zahner, Johannes</creator><creator>Borst, Mathias M</creator><creator>Worth, Heinrich</creator><creator>Raffin, Thomas A</creator><creator>Taylor, James R</creator><creator>Ryu, Jay</creator><creator>Colby, Thomas V</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19910704</creationdate><title>Treatment of Lymphangioleiomyomatosis</title><author>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphangiomyoma - therapy</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goodenberger, Daniel M</creatorcontrib><creatorcontrib>Dhand, Sandeep</creatorcontrib><creatorcontrib>Eliasson, Arn H</creatorcontrib><creatorcontrib>Phillips, Yancy Y</creatorcontrib><creatorcontrib>Tenholder, Michael F</creatorcontrib><creatorcontrib>Goodwin, Thomas Murphy</creatorcontrib><creatorcontrib>Zahner, Johannes</creatorcontrib><creatorcontrib>Borst, Mathias M</creatorcontrib><creatorcontrib>Worth, Heinrich</creatorcontrib><creatorcontrib>Raffin, Thomas A</creatorcontrib><creatorcontrib>Taylor, James R</creatorcontrib><creatorcontrib>Ryu, Jay</creatorcontrib><creatorcontrib>Colby, Thomas V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goodenberger, Daniel M</au><au>Dhand, Sandeep</au><au>Eliasson, Arn H</au><au>Phillips, Yancy Y</au><au>Tenholder, Michael F</au><au>Goodwin, Thomas Murphy</au><au>Zahner, Johannes</au><au>Borst, Mathias M</au><au>Worth, Heinrich</au><au>Raffin, Thomas A</au><au>Taylor, James R</au><au>Ryu, Jay</au><au>Colby, Thomas V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Lymphangioleiomyomatosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1991-07-04</date><risdate>1991</risdate><volume>325</volume><issue>1</issue><spage>63</spage><epage>64</epage><pages>63-64</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point. "Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>2046715</pmid><doi>10.1056/NEJM199107043250115</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1991-07, Vol.325 (1), p.63-64
issn 0028-4793
1533-4406
language eng
recordid cdi_crossref_primary_10_1056_NEJM199107043250115
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Adolescent
Combined Modality Therapy
Female
Humans
Lymphangiomyoma - therapy
Male
title Treatment of Lymphangioleiomyomatosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T00%3A43%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-mms_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Lymphangioleiomyomatosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Goodenberger,%20Daniel%20M&rft.date=1991-07-04&rft.volume=325&rft.issue=1&rft.spage=63&rft.epage=64&rft.pages=63-64&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM199107043250115&rft_dat=%3Cmms_cross%3ENJ199107043250115%3C/mms_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2046715&rfr_iscdi=true